These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions. Moore MW; Gasparini R Diagn Pathol; 2011 Aug; 6():76. PubMed ID: 21834951 [TBL] [Abstract][Full Text] [Related]
4. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis? Xavier-Junior JCC; Ocanha-Xavier JP Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551 [TBL] [Abstract][Full Text] [Related]
6. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus. King R; Page RN; Googe PB; Mihm MC Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811 [TBL] [Abstract][Full Text] [Related]
8. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. Meyer LJ; Piepkorn M; Goldgar DE; Lewis CM; Cannon-Albright LA; Zone JJ; Skolnick MH J Am Acad Dermatol; 1996 Apr; 34(4):618-25. PubMed ID: 8601651 [TBL] [Abstract][Full Text] [Related]
9. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes. Wakefield C; O'Keefe L; Heffron CCBB Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345 [TBL] [Abstract][Full Text] [Related]
10. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? Skender-Kalnenas TM; English DR; Heenan PJ J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345 [TBL] [Abstract][Full Text] [Related]
11. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features. Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759 [TBL] [Abstract][Full Text] [Related]
12. Large Acquired Nevus or Dysplastic Nevus: What's in the Name of a Nevus? Hofmann-Wellenhof R; Marghoob AA; Zalaudek I JAMA Dermatol; 2016 Jun; 152(6):623-4. PubMed ID: 26914472 [No Abstract] [Full Text] [Related]
13. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers. Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720 [TBL] [Abstract][Full Text] [Related]
14. Simulators of malignant melanoma of the skin. Cerroni L; Kerl H Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049 [TBL] [Abstract][Full Text] [Related]
15. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi. Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880 [TBL] [Abstract][Full Text] [Related]
16. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms? Zembowicz A; Scolyer RA Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452 [TBL] [Abstract][Full Text] [Related]
17. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study]. Sigg C; Pelloni F; Schnyder UW Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669 [TBL] [Abstract][Full Text] [Related]
18. Dysplastic nevus: why this term should be abandoned in dermatoscopy. Kittler H; Tschandl P Dermatol Clin; 2013 Oct; 31(4):579-88, viii. PubMed ID: 24075546 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions]. Lampert A; Thomine E; Lauret P; Hemet J Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667 [TBL] [Abstract][Full Text] [Related]
20. [Dysplastic nevus in differential epiluminescence microscopy diagnosis of melanoma]. Schulz H Hautarzt; 1996 Feb; 47(2):109-13. PubMed ID: 8868454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]